103 related articles for article (PubMed ID: 30833029)
1. Expression of vimentin in nasopharyngeal carcinoma and its possible molecular mechanism: A study based on immunohistochemistry and bioinformatics analysis.
Lu W; Luo JY; Wu MH; Hou JY; Yang X; Chen G; Feng ZB
Pathol Res Pract; 2019 May; 215(5):1020-1032. PubMed ID: 30833029
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
Luo W; Fang W; Li S; Yao K
Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
[TBL] [Abstract][Full Text] [Related]
3. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.
Xu L; Fan S; Zhao J; Zhou P; Chu S; Luo J; Wen Q; Chen L; Wen S; Wang L; Shi L
Diagn Pathol; 2017 Jan; 12(1):2. PubMed ID: 28061788
[TBL] [Abstract][Full Text] [Related]
5. Correlation between IL-17A expression in nasopharyngeal carcinoma tissues and cells and pathogenesis of NPC in endemic areas.
Wang LX; Ma RX; Di LL; Peng XB; Kang ZP; Zhong S
Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3131-3138. PubMed ID: 31456038
[TBL] [Abstract][Full Text] [Related]
6. Forkhead box C1 induces epithelial‑mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma.
Ou-Yang L; Xiao SJ; Liu P; Yi SJ; Zhang XL; Ou-Yang S; Tan SK; Lei X
Mol Med Rep; 2015 Dec; 12(6):8003-9. PubMed ID: 26461269
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinase 14 Overexpression Is Correlated with the Progression and Poor Prognosis of Nasopharyngeal Carcinoma.
Yan TH; Lin ZH; Jiang JH; Lu SW; Que HX; Chen MA; He XS; Que GB; Xiao JN; Chen YQ
Arch Med Res; 2015 Apr; 46(3):186-92. PubMed ID: 25829357
[TBL] [Abstract][Full Text] [Related]
8. EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.
Lu Y; Liang Y; Zheng X; Deng X; Huang W; Zhang G
J Exp Clin Cancer Res; 2019 Feb; 38(1):82. PubMed ID: 30770775
[TBL] [Abstract][Full Text] [Related]
9. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinoma.
Huang C; Tang H; Zhang W; She X; Liao Q; Li X; Wu M; Li G
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):166-75. PubMed ID: 22068284
[TBL] [Abstract][Full Text] [Related]
11. Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis.
Zhang X; Song X; Lai Y; Zhu B; Luo J; Yu H; Yu Y
BMC Cancer; 2021 Apr; 21(1):483. PubMed ID: 33931030
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
14. Expression of TWIST, an inducer of epithelial-mesenchymal transition, in nasopharyngeal carcinoma and its clinical significance.
Zhuo X; Chang A; Huang C; Yang L; Xiang Z; Zhou Y
Int J Clin Exp Pathol; 2014; 7(12):8862-8. PubMed ID: 25674256
[TBL] [Abstract][Full Text] [Related]
15. CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma.
Chang SL; Chen TJ; Lee YE; Lee SW; Lin LC; He HL
Int J Med Sci; 2018; 15(10):992-998. PubMed ID: 30013440
[No Abstract] [Full Text] [Related]
16. Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance.
Liu J; Tang G; Huang H; Li H; Zhang P; Xu L
Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2563-2573. PubMed ID: 30121842
[TBL] [Abstract][Full Text] [Related]
17. Annexin A1 can inhibit the in vitro invasive ability of nasopharyngeal carcinoma cells possibly through Annexin A1/S100A9/Vimentin interaction.
Xiao Y; Ouyang C; Huang W; Tang Y; Fu W; Cheng A
PLoS One; 2017; 12(3):e0174383. PubMed ID: 28355254
[TBL] [Abstract][Full Text] [Related]
18. Expression of LEF1 and TCF1 (TCF7) proteins associates with clinical progression of nasopharyngeal carcinoma.
Zhan Y; Feng J; Lu J; Xu L; Wang W; Fan S
J Clin Pathol; 2019 Jun; 72(6):425-430. PubMed ID: 30918012
[TBL] [Abstract][Full Text] [Related]
19. High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.
Liu Z; Wu K; Yang Z; Wu A
Mol Cell Biochem; 2015 Nov; 409(1-2):155-62. PubMed ID: 26183485
[TBL] [Abstract][Full Text] [Related]
20. EPHB2 as a recurrence-related gene and a prognostic indicator in nasopharyngeal carcinoma: A bioinformatics screening and immunohistochemistry verification.
Ling J; Chang A; Zhao H; Ye H; Zhuo X
Histol Histopathol; 2022 Sep; 37(9):889-897. PubMed ID: 35441696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]